8-K filed May 11, 2026 at 08:52 ET
Agenus reported Q1 2026 total revenue of $33.7M (up from $24.1M YoY) and net income of $39.2M vs a net loss of $26.4M in Q1 2025, driven by $29.1M in non-cash royalty revenue and $4.6M in pre-commercial product revenue from BOT+BAL early access programs. The company ended the quarter with $35.0M in cash (up from $3.0M at year-end 2025) after closing the Zydus collaboration, which delivered $91M in upfront capital. The SEC investigation concluded with no enforcement action, and the related securities class action was dismissed, removing two key legal overhangs.